Informa Life Sciences is part of the Knowledge and Networking Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.


Barry Frankel

Senior Advisor Strategy at FDNA


Barry has 40 years of experience in the life science industry, including company formation, investment research, strategic planning, licensing/mergers/acquisitions, and marketing.  Following several years of advising FDNA on business strategy, Barry was appointed Senior Advisor Strategy and Business Development for this leading provider of smart phenotyping applications for clinical genomics.  Barry is also a Co-Founder of a late development stage hospital injectable pharmaceutical company, Sedor Pharmaceuticals.  And, Barry is Executive Chairman of 8Tron, a global company developing and commercializing a novel neuromodulation platform for medical and consumer applications.

Barry was a Founder of Frankel Group LLC, a global boutique life science strategy consulting firm with offices in New York NY, Cambridge MA, and Tel Aviv IS.  Frankel Group provided product development, M&A, commercialization and corporate growth strategies to the leading global and emerging bio/pharmaceutical, medical device, diagnostics and health care service firms.  Frankel Group was acquired by Huron Consulting Group, where Barry assumed a Managing Director role in their expanded life science strategy group.

Prior to the above experience, Barry was a Partner and President of SJ Weinstein Associates Inc., a healthcare advertising and marketing strategy firm; a Director of Pfizer Pharmaceuticals where Barry was involved in business planning and M&A, as well as marketing management of Pfizer’s anti-infective pharmaceuticals and diagnostics businesses; and a Senior Research Officer for Citibank Investment Management Group responsible for equity investment recommendations in the life sciences.

Barry’s received a Bachelor of Science Summa Cum Laude in Engineering from Rutgers University, and a Master of Business Administration with Distinction in Finance from the Wharton School, University of Pennsylvania.

Barry serves on the Board of Directors for Cireca, BioAffinity, and Nanocare, and is an Advisor for Marathon Asset Management.  Barry also is Chairman of the Wainscott Citizens Advisory Council and is on the Advisory Board of Park Avenue Synagogue.

Barry Frankel's Network

Agenda Sessions